Elsevier

Experimental Cell Research

Volume 239, Issue 2, 15 March 1998, Pages 332-343
Experimental Cell Research

Regular Article
GFAP-Deficient Astrocytes Are Capable of Stellationin VitroWhen Cocultured with Neurons and Exhibit a Reduced Amount of Intermediate Filaments and an Increased Cell Saturation Density

https://doi.org/10.1006/excr.1997.3922Get rights and content
Under a Creative Commons license
open archive

Abstract

Glial fibrillary acidic protein (GFAP) is an intermediate filament protein predominantly expressed in cells of astroglial origin. To allow for the study of the biological functions of GFAP we have previously generated GFAP-negative mice by gene targeting [Peknyet al.(1995)EMBO J.14, 1590–1598]. Astrocytes in culture, similar to reactive astrocytesin vivo,express three intermediate filament proteins: GFAP, vimentin, and nestin. Using primary astrocyte-enriched cultures from GFAP-negative mice, we now report on the effect of GFAP absence on (i) the synthesis of other intermediate filament proteins in astrocytes, (ii) intermediate filament formation, (iii) astrocyte process formation (stellation) in response to neurons in mixed cerebellar astrocyte/neuron cultures, and (iv) saturation cell densityin vitro.GFAP−/− astrocytes were found to produce both nestin and vimentin. At the ultrastructural level, the amount of intermediate filaments as revealed by transmission electron microscopy was reduced in GFAP−/− astrocytes compared to that in GFAP+/+ astrocytes. GFAP−/− astrocytes retained the ability to form processes in response to neurons in mixed astrocyte/neuron cultures from the cerebellum. GFAP−/− astrocyte-enriched primary cultures exhibited an increased final cell saturation density. The latter leads us to speculate that the loss of GFAP expression observed focally in a proportion of human malignant gliomas may reflect tumor progression toward a more rapidly growing and malignant phenotype.

Cited by (0)

A. ShaharJ. de VellisA. VernadakisB. Haber

1

To whom correspondence and reprint requests should be addressed at Department of Medical Biochemistry, University of Göteborg, Box 440, SE-405 30 Göteborg, Sweden. Fax: (46) 31 416 108. E-mail:[email protected].